Trial Profile
Six years of real-life experience with rituximab in Germany
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Sep 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Acronyms GERINIS
- 25 Sep 2015 New trial record